-
公开(公告)号:EP2618665A4
公开(公告)日:2014-08-20
申请号:EP11827256
申请日:2011-09-16
发明人: MCCAULEY JOHN A , LIVERTON NIGEL J , RUDD MICHAEL T , GILBERT KEVIN F , FERRARA MARCO , SUMMA VINCENZO , CRESCENZI BENEDETTA
CPC分类号: A61K38/07 , A61K45/06 , C07D498/18 , C07K5/101 , C07K5/1016
-
公开(公告)号:EP2780026A4
公开(公告)日:2016-06-08
申请号:EP12850713
申请日:2012-11-09
发明人: RUDD MICHAEL T , MCCAULEY JOHN , LIVERTON NIGEL , GRISE-BARD CHRISTIANE , BROUCHU MARIE-CHRISTINE , CHARRON SYLVIE , AULAKH VIRENDER , BACHAND BENOIT , BEAULIEU PATRICK , ZAGHDANE HELMI , HAN YONGXIN , FERRARA MARCO , HARPER STEVEN , SUMMA VINCENZO , CHACKALAMANNIL SAMUEL , VENKATRAMAN SRIKANTH , SHAH UNMESH , VELAZQUEZ FRANCISCO
CPC分类号: C07K5/08 , A61K31/4745 , A61K31/5377 , A61K31/675 , A61K31/7056 , A61K38/005 , A61K38/06 , A61K38/12 , A61K38/21 , C07K5/0804 , C07K5/0808 , C07K5/0812 , C07K5/0821 , A61K2300/00
摘要: The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.
摘要翻译: 本发明涉及可用作丙型肝炎病毒(HCV)NS3蛋白酶抑制剂及其合成及其用于治疗或预防HCV感染的用途的式(I)的大环化合物。
-
3.QUINOLINE CARBOXAMIDE AND QUINOLINE CARBONITRILE DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE 有权
标题翻译: 作为MGLUR2阴离子调节剂,组合物及其用途的羧甲基羧酰胺和羧甲基碳纳米管衍生物公开(公告)号:EP2775841A4
公开(公告)日:2015-05-06
申请号:EP12846579
申请日:2012-10-26
申请人: MERCK SHARP & DOHME
发明人: BUNGARD CHRISTOPHER JAMES , CONVERSO ANTONELLA , DE LEON PABLO , HANNEY BARBARA , HARTINGH TIMOTHY JOHN , MANIKOWSKI JESSE JOSEF , MANLEY PETER J , MEISSNER ROBERT , MENG ZHAOYANG , PERKINS JAMES J , RUDD MICHAEL T , RUDD MICHAEL T , SHU YOUHENG
IPC分类号: A61K31/4725 , A61P25/04 , A61P25/20 , A61P25/28 , C07D215/48 , C07D401/06 , C07D401/14
CPC分类号: C07D413/14 , A61K31/47 , A61K31/4709 , A61K31/496 , A61K31/4985 , A61K31/506 , A61K31/5377 , A61K31/541 , C07D215/48 , C07D401/04 , C07D401/06 , C07D401/14 , C07D409/04 , C07D413/06 , C07D417/06 , C07D417/14 , C07D471/04 , C07D491/10
-
公开(公告)号:EP2271345A4
公开(公告)日:2011-08-31
申请号:EP09739426
申请日:2009-04-16
申请人: MERCK SHARP & DOHME
发明人: LIVERTON NIGEL J , MCCAULEY JOHN A , BUTCHER JOHN W , GILBERT KEVIN F , MCINTYRE CHARLES J , RUDD MICHAEL T
IPC分类号: C07D498/18 , A61K31/505 , A61P31/18
CPC分类号: C07K5/123 , A61K38/00 , C07D498/18 , C07K5/08 , C07K5/0804 , C07K5/0812
-
公开(公告)号:EP2334181A4
公开(公告)日:2012-03-14
申请号:EP09814974
申请日:2009-08-24
申请人: MERCK SHARP & DOHME
发明人: MCCAULEY JOHN A , HESS JOHN W , LIVERTON NIGEL J , MCINTYRE CHARLES J , ROMANO JOSEPH J , RUDD MICHAEL T
IPC分类号: A01N43/42 , A61K31/4439 , A61K51/04 , A61P1/00 , A61P3/10 , A61P25/08 , A61P25/14 , A61P25/16 , A61P25/18 , A61P25/22 , A61P25/24 , A61P25/28 , A61P27/02 , C07D401/12 , C07D401/14 , C07D417/12
CPC分类号: C07D401/14 , C07D401/12 , C07D417/12 , C07D471/04
-
公开(公告)号:EP2731439A4
公开(公告)日:2014-12-03
申请号:EP12811318
申请日:2012-07-06
申请人: MERCK SHARP & DOHME
发明人: HANNEY BARBARA , MANLEY PETER , RUDD MICHAEL T , SANDERS JOHN M , STACHEL SHAWN J , HENZE DARRELL
IPC分类号: A01N43/90 , A61K31/404 , C07D471/02
CPC分类号: C07D471/04 , C07D401/04 , C07D403/04 , C07D405/04 , C07D417/04 , C07D487/04
-
公开(公告)号:EP1879607A4
公开(公告)日:2010-03-31
申请号:EP06751833
申请日:2006-04-28
申请人: MERCK SHARP & DOHME
发明人: HOLLOWAY M KATHARINE , LIVERTON NIGEL J , LUDMERER STEVEN W , MCCAULEY JOHN A , OLSEN DAVID B , RUDD MICHAEL T , VACCA JOSEPH P
IPC分类号: A61K38/12
CPC分类号: C07K5/0808 , C07K5/0806 , C07K5/0812 , C07K5/0815 , C07K5/0821
-
公开(公告)号:EP2268285A4
公开(公告)日:2012-01-25
申请号:EP09714973
申请日:2009-02-12
IPC分类号: A61K31/70
CPC分类号: C07K5/0812 , A61K38/212 , A61K38/215 , A61K38/217 , C07K5/06078 , C07K5/0808 , A61K2300/00
摘要: A class of macrocyclic compounds of formula (I), wherein R1, R3, R4, Ra, Rb, A, B, Z, M, W and n are defined herein, that are useful as inhibitors of viral proteases, particularly the hepatitis C virus (HCV) NS3 protease, are provided. Also provided are processes for the synthesis and use of such macrocyclic compounds for treating or preventing HCV infection.
摘要翻译: 一类式(I)的大环化合物,其中R1,R3,R4,Ra,Rb,A,B,Z,M,W和n在本文中定义,其可用作病毒蛋白酶,特别是丙型肝炎的抑制剂 病毒(HCV)NS3蛋白酶。 还提供了用于合成和使用这种用于治疗或预防HCV感染的大环化合物的方法。
-
公开(公告)号:EP2079480A4
公开(公告)日:2011-06-15
申请号:EP07852883
申请日:2007-10-22
申请人: MERCK SHARP & DOHME
IPC分类号: C07D498/18 , A61K31/675 , A61P31/12
CPC分类号: C07D498/18
-
公开(公告)号:EP2083844A4
公开(公告)日:2010-12-01
申请号:EP07839741
申请日:2007-10-23
申请人: MERCK SHARP & DOHME
IPC分类号: A61K38/12 , A61K31/4741 , A61P31/00 , C07D519/00 , C07K5/12
CPC分类号: C07K5/0802 , A61K38/00 , C07D519/00
-
-
-
-
-
-
-
-
-